SOLO-1: Frontline Olaparib Maintenance Therapy in Ovarian Cancer

4 Visninger
administrator
administrator
07/08/23

Experts review the SOLO-1 trial and olaparib’s role as maintenance therapy following the frontline management of ovarian cancer.

Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive

  • Kategori

Vis mere

0 Kommentarer Sorter efter

Ingen kommentarer fundet

Facebook kommentarer

Næste